The ceRNA network suggested that MYO6 may target miR-143 and thus affect the expression of EGOT or PVT1, etc. The potential mechanism of its influence on lung cancer may involve extracellular matrix and structural organization, external encapsulating structure organization, the humoral immune response and cellular chemotaxis. This evidence concerns the gene EGOT and lung carcinoma.